Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (281-290 of 611) with videos related to

Pageof 62
Sort By:
Neuroscience Letters|April 12, 2001
Expression of tachykinin NK2 receptor mRNA in human brainM Bensaid, B A Faucheux, E Hirsch, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1994
High affinity neurotrophin receptors in cholinergic neurons in the human brainF Boissière, S Hunot, B Faucheux, et al.
Brain : a Journal of Neurology|March 2, 1999
DYT1 mutation in French families with idiopathic torsion dystoniaA S Lebre, A Durr, P Jedynak, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 1, 1994
Explicit memory, procedural learning and lexical priming in Alzheimer's diseaseB Deweer, A M Ergis, P Fossati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated miceH Turmel, A Hartmann, K Parain, et al.
Synapse (New York, N.Y.)|October 23, 2001
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian ratsC Marin, A Jiménez, M Bonastre, et al.
Neuroscience Letters|March 2, 1990
Tyrosine hydroxylase-like immunoreactivity in senile plaques is not related to the density of tyrosine hydroxylase-positive fibers in patients with Alzheimer's diseaseP Cervera, C Duyckaerts, M Ruberg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1989
Increased wave P 300 latency in progressive supranuclear palsyC Pierrot-Deseilligny, E Turell, C Penet, et al.
Neuroreport|April 20, 1999
Survival factors promote BDNF protein expression in mesencephalic dopaminergic neuronsM G Murer, R Raisman-Vozari, Q Yan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1995
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsyB Pillon, N Gouider-Khouja, B Deweer, et al.
Pageof 62

Showing results (281-290 of 611) with videos related to

Sort By:
Pageof 62
Neuroscience Letters|April 12, 2001
Expression of tachykinin NK2 receptor mRNA in human brainM Bensaid, B A Faucheux, E Hirsch, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1994
High affinity neurotrophin receptors in cholinergic neurons in the human brainF Boissière, S Hunot, B Faucheux, et al.
Brain : a Journal of Neurology|March 2, 1999
DYT1 mutation in French families with idiopathic torsion dystoniaA S Lebre, A Durr, P Jedynak, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 1, 1994
Explicit memory, procedural learning and lexical priming in Alzheimer's diseaseB Deweer, A M Ergis, P Fossati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated miceH Turmel, A Hartmann, K Parain, et al.
Synapse (New York, N.Y.)|October 23, 2001
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian ratsC Marin, A Jiménez, M Bonastre, et al.
Neuroscience Letters|March 2, 1990
Tyrosine hydroxylase-like immunoreactivity in senile plaques is not related to the density of tyrosine hydroxylase-positive fibers in patients with Alzheimer's diseaseP Cervera, C Duyckaerts, M Ruberg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1989
Increased wave P 300 latency in progressive supranuclear palsyC Pierrot-Deseilligny, E Turell, C Penet, et al.
Neuroreport|April 20, 1999
Survival factors promote BDNF protein expression in mesencephalic dopaminergic neuronsM G Murer, R Raisman-Vozari, Q Yan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1995
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsyB Pillon, N Gouider-Khouja, B Deweer, et al.
Pageof 62